Aridis Pharmaceuticals
ARDS----
Forecast & RatingOnly 1 analyst currently covers Aridis Pharmaceuticals (ARDS.US), with a price target of $2.00 and a rating of "Overweight". The sample is very small, so treat this as a reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Nov 6, 2023Price forecast
$2.00999900.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateMay 20, 2024
Forecast met0.0%
Stock price$0.06
Avg. target$2.0
High target$2
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.